Early Convalescent Plasma for High-Risk Outpatients with Covid-19 | Zendy

Frederick K. Korley | Zendy; Valerie DurkalskiMauldin | Zendy; Sharon D. Yeatts | Zendy; Kevin A. Schulman | Zendy; Robertson D. Davenport | Zendy; Larry J. Dumont | Zendy; Nahed El Kassar | Zendy; Lydia D. Foster | Zendy; Jennifer M. Hah | Zendy; Siddartha Jaiswal | Zendy; Alesia Kaplan | Zendy; Ezekiel Lowell | Zendy; John F. McDyer | Zendy; James Quinn | Zendy; Darrell J. Triulzi | Zendy; Carol Van Huysen | Zendy; Valerie L. Stevenson | Zendy; Kabir Yadav | Zendy; Christopher W. Jones | Zendy; Bory Kea | Zendy; Aaron Burnett | Zendy; Joshua C. Reynolds | Zendy; Colin F. Greineder | Zendy; Nathan L. Haas | Zendy; David G. Beiser | Zendy; Robert Silbergleit | Zendy; William G. Barsan | Zendy; Clifton W. Callaway | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Early Convalescent Plasma for High-Risk Outpatients with Covid-19

Author(s) -

Frederick K. Korley,

Valerie DurkalskiMauldin,

Sharon D. Yeatts,

Kevin A. Schulman,

Robertson D. Davenport,

Larry J. Dumont,

Nahed El Kassar,

Lydia D. Foster,

Jennifer M. Hah,

Siddartha Jaiswal,

Alesia Kaplan,

Ezekiel Lowell,

John F. McDyer,

James Quinn,

Darrell J. Triulzi,

Carol Van Huysen,

Valerie L. Stevenson,

Kabir Yadav,

Christopher W. Jones,

Bory Kea,

Aaron Burnett,

Joshua C. Reynolds,

Colin F. Greineder,

Nathan L. Haas,

David G. Beiser,

Robert Silbergleit,

William G. Barsan,

Clifton W. Callaway

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2103784

Subject(s) - medicine , placebo , randomization , emergency department , convalescent plasma , randomized controlled trial , intensive care unit , severity of illness , disease , covid-19 , infectious disease (medical specialty) , alternative medicine , pathology , psychiatry

Early administration of convalescent plasma obtained from blood donors who have recovered from coronavirus disease 2019 (Covid-19) may prevent disease progression in acutely ill, high-risk patients with Covid-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research